Seres Therapeutics, Inc.(MCRB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MCRB Seres Therapeutics, Inc.

交易中 08-07 13:13:20 EDT

4.87

+0.05

+1.04%

最高5.19	最低4.82	成交量4.33万
今开5.07	昨收4.82	日振幅7.60%
总市值4,841万	流通市值4,252万	总股本994.13万
成交额21.73万	换手率0.50%	流通股本873.11万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MCRB","market":"US","secType":"STK","nameCN":"Seres Therapeutics, Inc.","latestPrice":4.87,"timestamp":1786122789413,"preClose":4.82,"halted":0,"volume":43344,"delay":0,"changeRate":0.010373443983402453,"floatShares":8731100,"shares":9941300,"eps":-5.0751,"marketStatus":"交易中","change":0.05,"latestTime":"08-07 13:13:20 EDT","open":5.07,"high":5.1894,"low":4.823,"amount":217278.8645328,"amplitude":0.076017,"askPrice":4.92,"askSize":37,"bidPrice":4.82,"bidSize":210,"shortable":3,"etf":0,"ttmEps":-5.0751,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1786132800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1435291200000,"exchange":"NASDAQ","adjPreClose":4.82,"preHourTrading":{"tag":"盘前","latestPrice":5.13,"preClose":4.82,"latestTime":"07:34 EDT","volume":51,"amount":267.706191,"timestamp":1786102461118,"change":0.31,"changeRate":0.064315,"amplitude":0.027282},"postHourTrading":{"tag":"盘后","latestPrice":4.82,"preClose":4.82,"latestTime":"19:34 EDT","volume":99,"amount":477.24,"timestamp":1786059249837,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.098833,"impliedVol":1.5996,"impliedVolPercentile":0.7131},"requestUrl":"/m/hq/s/MCRB/tweets","defaultTab":"tweets","newsList":[{"id":"1152986150","title":"Seres Therapeutics公布2026年第二季度财报并更新业务进展，进一步采取行动削减设施运营成本","url":"https://stock-news.laohu8.com/highlight/detail?id=1152986150","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152986150?lang=zh_cn&edition=full","pubTime":"2026-08-05 19:01","pubTimestamp":1785927697,"startTime":"0","endTime":"0","summary":"Seres Therapeutics, Inc. 发布了截至2026年6月30日的第二季度财务业绩。与此同时，该公司还披露了业务最新动态，其中一项关键举措是进一步采取措施，以降低持续的设施相关费用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MCRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169727081","title":"Seres Therapeutics于7月31日达成提前终止租赁协议，削减设施开支","url":"https://stock-news.laohu8.com/highlight/detail?id=1169727081","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169727081?lang=zh_cn&edition=full","pubTime":"2026-08-05 04:31","pubTimestamp":1785875475,"startTime":"0","endTime":"0","summary":"Seres Therapeutics公司与Bmr-Sidney Research Campus LLC在7月31日签署了一份提前终止租赁的协议。此举旨在有效降低设施相关成本支出。通过这项安排，企业能够灵活调整其不动产资源配置，减轻长期的财务负担。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MCRB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186585214","title":"Seres Therapeutics 宣布 Ser-155 耐受性良好，至第43天未出现药物相关严重不良事件","url":"https://stock-news.laohu8.com/highlight/detail?id=1186585214","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186585214?lang=zh_cn&edition=full","pubTime":"2026-07-08 19:02","pubTimestamp":1783508539,"startTime":"0","endTime":"0","summary":"Seres Therapeutics 公司报告称，其候选药物 Ser-155 在临床研究中展现出良好的耐受性。截至第43天的观察数据，未出现与药物相关的严重不良事件。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MCRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188826412","title":"Seres Therapeutics - 在首次临床试验中，80%的Ser-155受试者在第15天实现无免疫抑制应答","url":"https://stock-news.laohu8.com/highlight/detail?id=1188826412","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188826412?lang=zh_cn&edition=full","pubTime":"2026-07-08 19:01","pubTimestamp":1783508512,"startTime":"0","endTime":"0","summary":"Seres Therapeutics宣布，其候选药物Ser-155在一项首次临床试验中取得了积极结果。数据显示，高达80%的受试者在给药后第15天即实现了无需使用免疫抑制剂的治疗应答。这一早期数据展现了该疗法在调控免疫反应方面的潜力，为后续开发奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MCRB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128336377","title":"Seres Therapeutics公布早期临床数据，Ser-155在免疫检查点抑制剂相关肠炎中展现潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=1128336377","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128336377?lang=zh_cn&edition=full","pubTime":"2026-07-08 19:01","pubTimestamp":1783508484,"startTime":"0","endTime":"0","summary":"Seres Therapeutics公布了其候选药物Ser-155在治疗免疫检查点抑制剂相关肠炎方面的早期临床数据。它常常导致患者不得不暂停或终止关键的抗癌治疗，从而影响整体疗效。Ser-155旨在通过调节肠道微生物组来应对这一挑战。公布的早期临床数据表明，Ser-155在患者中显示出良好的安全性和耐受性。公司表示，将继续推进Ser-155的临床开发计划，以进一步验证其安全性和有效性。如果后续研究成功，Ser-155有望成为解决免疫检查点抑制剂相关肠炎这一未满足医疗需求的重要选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MCRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172930371","title":"Seres Therapeutics重组租赁协议，以削减年度设施现金成本与长期租赁负债","url":"https://stock-news.laohu8.com/highlight/detail?id=1172930371","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172930371?lang=zh_cn&edition=full","pubTime":"2026-06-05 19:03","pubTimestamp":1780657394,"startTime":"0","endTime":"0","summary":"Seres Therapeutics宣布，公司已对其现有租赁协议进行重组，此举旨在显著降低年度设施相关的现金支出，并有效缩减其长期租赁负债规模。通过调整租赁条款，公司期望优化其成本结构，为未来的运营与发展释放更多财务灵活性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MCRB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123033500","title":"Seres Therapeutics宣布两项交易以强化资产负债表，降低持续租赁成本，并将预计运营现金跑道大幅延长至2027年第一季度","url":"https://stock-news.laohu8.com/highlight/detail?id=1123033500","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123033500?lang=zh_cn&edition=full","pubTime":"2026-06-05 19:01","pubTimestamp":1780657293,"startTime":"0","endTime":"0","summary":"Seres Therapeutics宣布了两项关键交易，旨在显著增强公司资产负债表，同时有效降低持续产生的租赁成本。这些举措预计将把公司的运营现金跑道大幅延长，稳稳推进至2027年第一季度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MCRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100805786","title":"Seres Therapeutics 公布财务状况：截至2026年3月31日持有2980万美元现金及等价物，预计运营资金可支撑至2026年第三季度","url":"https://stock-news.laohu8.com/highlight/detail?id=1100805786","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100805786?lang=zh_cn&edition=full","pubTime":"2026-05-05 19:14","pubTimestamp":1777979642,"startTime":"0","endTime":"0","summary":"根据最新披露的财务数据，Seres Therapeutics Inc.（简称Seres）截至2026年3月31日持有的现金及现金等价物总额达到2980万美元。该公司预计，现有资金将足以支持其运营活动持续进行至2026年第三季度。\n这一资金状况为Seres Therapeutics在关键时期的业务发展提供了重要保障。充足的现金储备将助力公司推进研发管线，并维持日常运营的稳定性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MCRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135555687","title":"Seres Therapeutics任命Richard N. Kender为执行董事长兼临时CEO，并同步披露业务进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1135555687","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135555687?lang=zh_cn&edition=full","pubTime":"2026-03-03 05:06","pubTimestamp":1772485581,"startTime":"0","endTime":"0","summary":"Seres Therapeutics（股票代码：MCRB）近日宣布，公司已正式任命Richard N. Kender担任执行董事长兼临时首席执行官。与此同时，该公司还对外公布了最新的业务动态与战略进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MCRB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198061970","title":"Seres Therapeutics公布项目与企业最新动态 优先布局炎症与免疫疾病新兴疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1198061970","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198061970?lang=zh_cn&edition=full","pubTime":"2026-02-12 20:04","pubTimestamp":1770897884,"startTime":"0","endTime":"0","summary":"Seres Therapeutics公司今日宣布了其研发管线及企业运营的最新进展，并明确将炎症与免疫疾病领域的新兴治疗项目作为未来发展的战略重点。公司表示，此举旨在集中资源推进具有高潜力的创新疗法，以应对当前未满足的临床需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MCRB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194388706","title":"Seres Therapeutics宣布延长运营周期举措，包括裁员约30%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194388706","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194388706?lang=zh_cn&edition=full","pubTime":"2026-02-12 20:02","pubTimestamp":1770897723,"startTime":"0","endTime":"0","summary":"生物制药公司Seres Therapeutics, Inc.近期宣布实施一系列旨在延长企业运营周期的战略调整措施。作为成本优化计划的重要组成部分，该公司决定精简组织架构，将全球员工规模缩减约30%。此次人员调整预计将有效降低运营支出，为核心研发项目争取更充裕的资金支持周期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MCRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507621613","title":"Seres Therapeutics, Inc.盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507621613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507621613?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:41","pubTimestamp":1738248072,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时41分，Seres Therapeutics, Inc.股票出现波动，股价急速上涨5.08%。Seres Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Kazia Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Alterity Therapeutics Limited、Silexion Therapeutics Corp较为活跃，换手率分别为977.27%、138.27%、119.58%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Kazia Therapeutics Limited、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为56.41%、41.30%、28.90%。Seres Therapeutics, Inc.公司简介：Seres Therapeutics Inc 是一家在美国运营的微生物治疗平台公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130224112a2345710&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130224112a2345710&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MCRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506305440","title":"Seres Therapeutics, Inc.盘中异动 股价大涨5.06%报0.906美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506305440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506305440?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:43","pubTimestamp":1737988984,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时43分，Seres Therapeutics, Inc.股票出现异动，股价大幅上涨5.06%。截至发稿，该股报0.906美元/股，成交量8.6715万股，换手率0.05%，振幅5.06%。Seres Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。Seres Therapeutics, Inc.公司简介：Seres Therapeutics Inc 是一家在美国运营的微生物治疗平台公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272243059874b169&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272243059874b169&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MCRB","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505017943","title":"Seres Therapeutics, Inc.盘中异动 早盘快速跳水5.49%报0.862美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505017943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505017943?lang=zh_cn&edition=full","pubTime":"2025-01-23 23:10","pubTimestamp":1737645044,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日23时10分，Seres Therapeutics, Inc.股票出现异动，股价大幅跳水5.49%。Seres Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，Hepion Pharmaceuticals, Inc.、Nutriband Inc C/Wts 、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Hepion Pharmaceuticals, Inc.、Quoin Pharmaceuticals Ltd、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2963.31%、595.94%、51.07%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Nutriband Inc C/Wts 、Quoin Pharmaceuticals Ltd，振幅分别为54.22%、49.73%、37.79%。Seres Therapeutics, Inc.公司简介：Seres Therapeutics Inc 是一家在美国运营的微生物治疗平台公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123231045abb60326&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123231045abb60326&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MCRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505231726","title":"Seres Therapeutics, Inc.盘中异动 急速上涨6.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505231726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505231726?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:31","pubTimestamp":1737556281,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日22时31分，Seres Therapeutics, Inc.股票出现异动，股价快速上涨6.57%。Seres Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Immunoprecise Antibodies Ltd.、Nutriband Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Immunoprecise Antibodies Ltd.、Hepion Pharmaceuticals, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为431.36%、86.69%、50.64%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Cero Therapeutics Holdings, Inc.、Metagenomi, Inc.，振幅分别为20.57%、11.26%、9.93%。Seres Therapeutics, Inc.公司简介：Seres Therapeutics Inc 是一家在美国运营的微生物治疗平台公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223121986f7789&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223121986f7789&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MCRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505272563","title":"Seres Therapeutics, Inc.盘中异动 早盘股价大跌5.79%报0.723美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505272563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505272563?lang=zh_cn&edition=full","pubTime":"2025-01-21 23:03","pubTimestamp":1737471819,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日23时03分，Seres Therapeutics, Inc.股票出现波动，股价快速跳水5.79%。Seres Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.09%。其相关个股中，Channel Therapeutics Corporation、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Dogwood Therapeutics, Inc.涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为671.12%、191.61%、170.24%，振幅较大的相关个股有Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Genelux Corporation，振幅分别为92.63%、38.48%、22.35%。Seres Therapeutics, Inc.公司简介：Seres Therapeutics Inc 是一家在美国运营的微生物治疗平台公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121230339a22a5e70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121230339a22a5e70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MCRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504161962","title":"Seres Therapeutics, Inc.盘中异动 股价大涨5.44%报0.775美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504161962","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504161962?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:34","pubTimestamp":1737124445,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日22时34分，Seres Therapeutics, Inc.股票出现异动，股价快速上涨5.44%。Seres Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Channel Therapeutics Corporation涨幅较大，Aditxt, Inc.、Aeon Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为97.46%、14.69%、7.82%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Surrozen Inc C/Wts 01/08/2031 、Allakos Inc.，振幅分别为44.21%、25.64%、10.99%。Seres Therapeutics, Inc.公司简介：Seres Therapeutics Inc 是一家在美国运营的微生物治疗平台公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223405a225bc8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223405a225bc8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MCRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503642653","title":"Seres Therapeutics, Inc.盘中异动 股价大涨5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503642653","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503642653?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:30","pubTimestamp":1736951444,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时30分，Seres Therapeutics, Inc.股票出现波动，股价快速拉升5.70%。截至发稿，该股报0.810美元/股，成交量2.2149万股，换手率0.01%，振幅3.91%。Seres Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Os Therapies Incorporated、Exicure, Inc.、Generation Bio Co.涨幅较大，Windtree Therapeutics, Inc.、Os Therapies Incorporated、Phio Pharmaceuticals Corp.较为活跃，换手率分别为183.07%、51.82%、49.43%，振幅较大的相关个股有Onconetix, Inc.、Os Therapies Incorporated、Kairos Pharma, Ltd.，振幅分别为9.31%、6.01%、4.64%。Seres Therapeutics, Inc.公司简介：Seres Therapeutics Inc 是一家在美国运营的微生物治疗平台公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152230459604b36c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152230459604b36c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MCRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503077875","title":"Seres Therapeutics, Inc.盘中异动 急速跳水5.11%报0.781美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503077875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503077875?lang=zh_cn&edition=full","pubTime":"2025-01-15 01:39","pubTimestamp":1736876398,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日01时39分，Seres Therapeutics, Inc.股票出现异动，股价快速下挫5.11%。Seres Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.73%。其相关个股中，Eterna Therapeutics Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Eterna Therapeutics Inc.、Phio Pharmaceuticals Corp.、Soligenix, Inc.较为活跃，换手率分别为985.68%、528.21%、414.25%，振幅较大的相关个股有Eterna Therapeutics Inc.、Matinas Biopharma Holdings, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为170.74%、69.81%、69.33%。Seres Therapeutics, Inc.公司简介：Seres Therapeutics Inc 是一家在美国运营的微生物治疗平台公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011501395898662229&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011501395898662229&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MCRB","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503538922","title":"Seres Therapeutics, Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503538922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503538922?lang=zh_cn&edition=full","pubTime":"2025-01-14 01:07","pubTimestamp":1736788061,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日01时07分，Seres Therapeutics, Inc.股票出现波动，股价急速跳水5.02%。截至发稿，该股报0.802美元/股，成交量67.725万股，换手率0.40%，振幅3.28%。Seres Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.较为活跃，换手率分别为12357.37%、7063.60%、602.52%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为336.09%、216.61%、201.86%。Seres Therapeutics, Inc.公司简介：Seres Therapeutics Inc 是一家在美国运营的微生物治疗平台公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114010741aba9559e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114010741aba9559e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MCRB","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.serestherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0084},{"period":"1month","weight":-0.4079},{"period":"3month","weight":-0.374},{"period":"6month","weight":-0.6547},{"period":"1year","weight":-0.6503},{"period":"ytd","weight":-0.6761}],"compareEarnings":[{"period":"1week","weight":0.0362},{"period":"1month","weight":0.0279},{"period":"3month","weight":0.0419},{"period":"6month","weight":0.1129},{"period":"1year","weight":0.2146},{"period":"ytd","weight":0.1271}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Seres Therapeutics, Inc.于2010年10月根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，专注于为医疗脆弱人群开发活体生物治疗产品。其研发管线针对感染及炎症和免疫疾病，并利用首个获得FDA批准的口服微生物组疗法VOWST的开发经验所建立的平台。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":-0.014164},{"month":2,"riseRate":0.090909,"avgChangeRate":-0.098792},{"month":3,"riseRate":0.636364,"avgChangeRate":0.004905},{"month":4,"riseRate":0.454545,"avgChangeRate":-0.059133},{"month":5,"riseRate":0.545455,"avgChangeRate":-0.051264},{"month":6,"riseRate":0.545455,"avgChangeRate":0.059527},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.062757},{"month":8,"riseRate":0.583333,"avgChangeRate":0.549927},{"month":9,"riseRate":0.636364,"avgChangeRate":0.016793},{"month":10,"riseRate":0.090909,"avgChangeRate":-0.103019},{"month":11,"riseRate":0.636364,"avgChangeRate":0.091854},{"month":12,"riseRate":0.090909,"avgChangeRate":-0.100447}],"exchange":"NASDAQ","name":"Seres Therapeutics, Inc.","nameEN":"Seres Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Seres Therapeutics, Inc.(MCRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Seres Therapeutics, Inc.(MCRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Seres Therapeutics, Inc.,MCRB,Seres Therapeutics, Inc.股票,Seres Therapeutics, Inc.股票老虎,Seres Therapeutics, Inc.股票老虎国际,Seres Therapeutics, Inc.行情,Seres Therapeutics, Inc.股票行情,Seres Therapeutics, Inc.股价,Seres Therapeutics, Inc.股市,Seres Therapeutics, Inc.股票价格,Seres Therapeutics, Inc.股票交易,Seres Therapeutics, Inc.股票购买,Seres Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Seres Therapeutics, Inc.(MCRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Seres Therapeutics, Inc.(MCRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}